Tetanus prevention after injury: study of siltartoxatug
Part of Infections clinical trials.
This study compares a new tetanus shot (siltartoxatug) with standard tetanus treatments to see if it works as well. It is for people aged 18 and older who need tetanus protection after an injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are getting a tetanus shot with siltartoxatug, or another tetanus treatment like human tetanus immunoglobulin (HTIG), tetanus antitoxin (TAT), or a special fragment of equine antibody (F(ab')₂).
- You are receiving or will receive standard wound care.
- You (or your legal representative) can sign a consent form to join the study.
- You do not have a life expectancy less than 3 months.
- You do not have severe cognitive issues or other conditions that would make it hard to check for tetanus, and you are not in another treatment trial (observational studies are okay).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry collects information on people who receive the study drug Siltartoxatug to prevent tetanus after an injury. It helps researchers learn more about how the drug works in real-world use.
This trial tests a new injection (SNA02-48) designed to protect adults who are at high risk of tetanus infection. Tetanus is a serious bacterial infection that can cause severe muscle stiffness and life-threatening complications; this study evaluates whether this new protective treatment is safe and effective.
This trial tests a new medicine made from antibodies that target tetanus toxin. It may help protect people from tetanus without needing a vaccine.
This trial tests a new medicine called GR2001 to help prevent tetanus after a dirty wound. It is for people who have not had many tetanus shots before and need extra protection.
This study looks at how well a tetanus booster vaccine works by testing your saliva and blood. It includes healthy children, young adults, pregnant women, and adults with certain medical conditions.
This study tests a new type of patch with tiny needles (microneedles) that delivers a tetanus vaccine booster through your skin instead of a traditional injection. Researchers want to confirm it's safe and works well in healthy adults.
Hear when a new Tetanus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.